Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

European stocks rise as sentiment improves; Dax up 0.16%

Published 04/01/2015, 03:59 AM
Updated 04/01/2015, 03:59 AM
© Reuters.  European stocks open higher as Chinese data supports, financials lead

Investing.com - European stocks were mostly higher on Wednesday, boosted by the financial sector and as upbeat Chinese manufacturing data lent support to market sentiment while investors continued to focus on discussions over Greek bailout funds.

During European morning trade, the EURO STOXX 50 rose 0.34%, France’s CAC 40 climbed 0.58%, while Germany’s DAX 30 added 0.16%.

Sentiment was boosted after data earlier showed that manufacturing activity in China swung back into expansion territory last month. China's manufacturing purchasing managers' index rose to 50.1 in March from a reading of 49.9 the previous month, confounding expectations for a slip to 49.7.

Investors remained cautious however amid concerns over whether Greece can reach a compromise with its creditors in time to unlock more bailout funds before it runs out of cash in three weeks, as negotiations over economic reforms dragged on.

Financial stocks were broadly higher, as French lenders BNP Paribas (PARIS:BNPP) and Societe Generale (PARIS:SOGN) rallied 1.04% and 1.36%, while Germany's Deutsche Bank (XETRA:DBKGn) and Commerzbank (XETRA:CBKG) gained 0.45% and 1.33%.

Among peripheral lenders, Italy's Unicredit (MILAN:CRDI) and Intesa Sanpaolo (MILAN:ISP) advanced 0.63% and 1.30% respectively, while Banco Santander (MADRID:SAN) and BBVA (MADRID:BBVA) rose 0.17% and slipped 0.36%.

In London, FTSE 100 rose 0.39%, as U.K. lenders tracked their European counterparts sharply higher.

Shares in HSBC Holdings (LONDON:HSBA) gained 0.66% and the Royal Bank of Scotland (LONDON:RBS) jumped 1.35%, while Lloyds Banking (LONDON:LLOY) rallied 1.38% and Barclays (LONDON:BARC) surged 2.35%.

Glaxosmithkline (LONDON:GSK) added to gains, with shares climbing 1.60% following news the drugmaker's venture arm SR One joined a syndicate backing a big midstage study of a new kidney drug developed by Montreal-based Thrasos Therapeutics.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Meanwhile, mining stocks were broadly lower as Glencore Xstrata (LONDON:GLEN) dropped 0.68% and Bhp Billiton (LONDON:BLT) retreated 0.86%, while Antofagasta (LONDON:ANTO) tumbled 1.50%.

In the U.S., equity markets pointed to a lower open. The Dow Jones Industrial Average futures pointed to a 0.30% fall, S&P 500 futures signaled a 0.39% decline, while the Nasdaq 100 futures indicated a 0.36% loss.

Later in the day, the U.S. was to release the ADP nonfarm payrolls report, while the Institute of Supply Management was to release data on manufacturing activity.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.